# Moelis & Co: overview MC · NYSE · CIK 1596967 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/mc.md) · [Financials](/companies/mc/financials.md) · [Filings](/companies/mc/filings.md) · [Insiders](/companies/mc/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Free cash flow | $m | [135 d](/filings/0001193125-25-256727.md) | [313 d](/filings/0001193125-26-076747.md) | [(169)](/filings/0001193125-26-192462.md) | [199 d](/filings/0001193125-26-324296.md) | [180 d](/filings/0001193125-25-256727.md) | [330 d](/filings/0001193125-26-076747.md) | [(292)](/filings/0001193125-26-192462.md) | [216 d](/filings/0001193125-26-324296.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL not reported. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | | Free cash flow | $m | [921](/filings/0000950170-24-018791.md) | [27.0](/filings/0000950170-25-029070.md) | [142](/filings/0001193125-26-076747.md) | [415](/filings/0001193125-26-076747.md) | [540](/filings/0001193125-26-076747.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. - Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss. - Diluted EPS. XBRL not reported. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mc/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $592.6m | 9,057,944 | | Added +255,835 | | [KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC](/funds/1021223.md) | 2026-06-30 | $354.1m | 5,412,938 | | Reduced −364,835 | | [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $293.6m | 4,487,258 | | Reduced −141,425 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $219.2m | 3,351,361 | | Added +36,321 | | [WASATCH ADVISORS LP](/funds/814133.md) | 2026-06-30 | $212.4m | 3,246,593 | | Reduced −496,031 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $199.2m | 3,044,858 | | Added +123,729 | | [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $193.3m | 2,955,235 | | Added +252,053 | | [LONDON CO OF VIRGINIA](/funds/1259887.md) | 2026-06-30 | $182.6m | 2,791,199 | | Reduced −112,748 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $154.4m | 2,359,476 | | Added +190,223 | | [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $153.4m | 2,344,828 | | Added +197,636 | ## Recent filings [All 1,415 filings](/companies/mc/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-07-30 | 17:43 ET | [10-Q](/filings/0001193125-26-324296.md) | Quarterly report, period 2026-06-30 | 0001193125-26-324296 | | 2026-07-29 | 16:15 ET | [8-K](/filings/0001193125-26-323758.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-323758 | | 2026-06-26 | 17:00 ET | [8-K](/filings/0001193125-26-285661.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-285661 | | 2026-04-30 | 21:18 ET | [DEF 14A](/filings/0001193125-26-193242.md) | Proxy statement, period 2026-06-25 | 0001193125-26-193242 | | 2026-04-30 | 17:50 ET | [10-Q](/filings/0001193125-26-192462.md) | Quarterly report, period 2026-03-31 | 0001193125-26-192462 | | 2026-04-29 | 16:15 ET | [8-K](/filings/0001193125-26-191621.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-191621 | | 2026-02-26 | 16:16 ET | [10-K](/filings/0001193125-26-076747.md) | Annual report, period 2025-12-31 | 0001193125-26-076747 | | 2026-02-04 | 16:15 ET | [8-K](/filings/0001193125-26-037612.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-037612 | | 2025-10-30 | 17:39 ET | [10-Q](/filings/0001193125-25-256727.md) | Quarterly report, period 2025-09-30 | 0001193125-25-256727 | | 2025-10-29 | 16:15 ET | [8-K](/filings/0001193125-25-256346.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-256346 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-076747.md), filed Feb 26, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1596967 - Tickers: MC - Exchange: NYSE - SIC code: 6282 Investment Advice - State of incorporation: DE - Filer category: Large accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.